CTNNA3: Arrythmogenic Right Ventricular Cardiomyopathy Mode of Inheritance: Autosomal dominant inheritance (HP:0000006) HGNC: 2511 MONDO:0016587 Expert Panel: Arrythmogenic Right Ventricular Cardiomyopathy
Three papers were reviewed related to CTNNA3 and ARVD (23136403, 21254927, 224213630). In one paper the CTNNA3 gene was analyzed in 76 ARVD probands that were negative for PKP2, DSP, DSG2, DSC2, and JUP. In one of the probands the heterozygous NM_013266.3(CTNNA3):c.281T>A p.(Val94Asp) variant was found. This variant was not observed in 245296 reference alleles from gnomAD and was not present in both healthy parents and brother suggesting that the variant occurred de novo. Unfortunately no information was given about paternity testing or family history for ARVD. Another proband showed the heterozygous variant NM_013266.3(CTNNA3):c.2296_2298del p.(Leu766del). This variant was not found in 30971 reference alleles from gnomAD but was inherited from her father that only showed a mild right ventricular dilation. Her ant inherited the variant as well but she was asymptomatic. Yeast two-hybrid studies with both variants showed some aberrations (23136403). In another paper a missense variant was found in one of 55 Danish ARVD patients. The variant was found 37 times in 276338 (1 times homozygous) reference alleles in gnomAD making it less likely as a causal variant. In addition the proband did carry a missense variant of unknown significance in DSP (21254927). Germline knockout of alphaT-catenin encoded by ctnna3 in the mouse alters PKP2 distribution without affecting other junctional components of the areae Compositae. These mutant mice exhibit progressive dilated cardiomyopathy, gap junction remodelling, and increased sensitivity to ventricular arrhythmia following acute ischaemia, but not spontaneous ARVC (224213630). Total genetic evidence points calculated = 1.5; Total experimental evidence points calculated = 2; Total awarded points = 3.5; Final classification = Limited.
The GenCC data are available free of restriction under a CC0 1.0 Universal (CC0 1.0) Public Domain Dedication. The GenCC requests that you give attribution to GenCC and the contributing sources whenever possible and appropriate. The accepted Flagship manuscript is now available from Genetics in Medicine (https://www.gimjournal.org/article/S1098-3600(22)00746-8/fulltext).
The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. The GenCC does not independently verify the submitted information. Though the information is obtained from sources believed to be reliable, no warranty, expressed or implied, is made regarding accuracy, adequacy, completeness, reliability or usefulness of any information. This disclaimer applies to both isolated and aggregate uses of the information. The information is provided on an "as is" basis, collected through periodic submission and therefore may not represent the most up-to-date information from the submitters. If you have questions about the medical relevance of information contained on this website, please see a healthcare professional; if you have questions about specific gene-disease claims, please contact the relevant sources; and if you have questions about the representation of the data on this website, please contact gencc@thegencc.org.